Myocardial Infarction
AI-identified CAC via routine CT scan may reveal risk for heart attack, stroke
Routine CT scans could serve as a useful tool to identify patients at high risk for atherosclerotic CVD when paired with a deep learning algorithm that calculated coronary artery calcium scores, researchers reported.
FIRE: Complete revascularization benefits older patients with MI, multivessel disease
In patients aged 75 years or older with MI and multivessel CAD, physiology-guided complete revascularization improved outcomes compared with treating the culprit lesion only, according to the results of the FIRE trial.
Chest pain 1 year after heart attack points to worse long-term survival
Moderate to extreme chest pain reported 1 year after an MI may be indicative of increased mortality risk, according to a study published in the Journal of the American Heart Association.
Excess heart attack mortality occurs during heat waves, days of poor air quality in China
Researchers in China estimated that nearly 3% of all MI deaths in Jiangsu province during a 5-year period could be attributed to a combination of extreme temperature exposure and poor air quality.
Heart benefits of ‘weekend warrior’ physical activity similar to everyday exercise
People who concentrate physical activity into 1 to 2 days per week — so-called “weekend warriors” — derive CV benefits that are similar to those who spread exercise activity more evenly throughout the week, researchers reported.
FDA designates recall of troponin tests producing false-negative MI results as class I
The FDA announced that it has designated a recall of blood tests for cardiac troponin shown to produce false negatives for MI as class I, the most serious kind.
Testosterone therapy increases CVD risks for cisgender women, but not transgender adults
Testosterone use increases risks for cardiovascular disease, coronary artery disease and stroke among cisgender women, but not among transgender adults, according to a study published in The Journal of Clinical Endocrinology & Metabolism.
Single high-sensitivity troponin I test below 2 ng/L rules out MI in early presenters
One high-sensitivity cardiac troponin I measurement under the limit of detection — 2 ng/L — may be enough to rule out MI with high sensitivity among patients who present within 12 hours of symptom onset, researchers reported.
Trial of vitamin D supplementation raises questions about CV effects on older adults
In a trial of more than 20,000 older adults, vitamin D supplementation trended toward reducing risk for major CV events in older adults compared with placebo, a finding differing from previous studies.
‘Simply stunning’: Bempedoic acid may cut CVD risk for primary prevention patients by 30%
SAN DIEGO — In adults with elevated cardiovascular risk but without a prior clinical event and deemed statin intolerant, bempedoic acid reduced risk for major adverse CV events by 30% compared with placebo, researchers reported.